Ad is loading...
GLUE
Price
$7.74
Change
-$0.74 (-8.73%)
Updated
Nov 15 closing price
115 days until earnings call
MDGL
Price
$288.58
Change
-$14.09 (-4.66%)
Updated
Nov 15 closing price
100 days until earnings call
Ad is loading...

GLUE vs MDGL

Header iconGLUE vs MDGL Comparison
Open Charts GLUE vs MDGLBanner chart's image
Monte Rosa Therapeutics
Price$7.74
Change-$0.74 (-8.73%)
Volume$881.29K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$288.58
Change-$14.09 (-4.66%)
Volume$945.98K
CapitalizationN/A
GLUE vs MDGL Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GLUE vs. MDGL commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a StrongSell and MDGL is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GLUE: $7.74 vs. MDGL: $288.58)
Brand notoriety: GLUE and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 31% vs. MDGL: 223%
Market capitalization -- GLUE: $475.52M vs. MDGL: $6.29B
GLUE [@Biotechnology] is valued at $475.52M. MDGL’s [@Biotechnology] market capitalization is $6.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLUE and MDGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 6 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 6 bullish, 4 bearish.
  • MDGL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than MDGL.

Price Growth

GLUE (@Biotechnology) experienced а -16.41% price change this week, while MDGL (@Biotechnology) price change was -17.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 13, 2025.

MDGL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.29B) has a higher market cap than GLUE($476M). GLUE YTD gains are higher at: 36.991 vs. MDGL (24.721). GLUE has higher annual earnings (EBITDA): -131.78M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. GLUE (262M). GLUE has less debt than MDGL: GLUE (44.4M) vs MDGL (119M). MDGL has higher revenues than GLUE: MDGL (76.8M) vs GLUE (5.76M).
GLUEMDGLGLUE / MDGL
Capitalization476M6.29B8%
EBITDA-131.78M-502.65M26%
Gain YTD36.99124.721150%
P/E RatioN/AN/A-
Revenue5.76M76.8M7%
Total Cash262M999M26%
Total Debt44.4M119M37%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEMDGL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
87%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JULQ25.05-0.03
-0.10%
Innovator Premium Income 40 Bar ETF -Jul
PSCC37.69-0.19
-0.50%
Invesco S&P SmallCap Consumer Stapl ETF
UOCT35.10-0.23
-0.64%
Innovator U.S. Equity Ultra Buf ETF™ Oct
NLR87.94-0.71
-0.80%
VanEck Uranium & Nuclear ETF
DFSV32.25-0.27
-0.83%
Dimensional US Small Cap Value ETF

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-8.73%
RXRX - GLUE
49%
Loosely correlated
-10.64%
MDGL - GLUE
47%
Loosely correlated
-4.66%
PRTA - GLUE
43%
Loosely correlated
-12.98%
RCKT - GLUE
41%
Loosely correlated
-5.67%
BEAM - GLUE
40%
Loosely correlated
-8.59%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with VXRT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then VXRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-4.66%
VXRT - MDGL
61%
Loosely correlated
-7.92%
ALXO - MDGL
56%
Loosely correlated
-3.01%
REPL - MDGL
55%
Loosely correlated
-5.26%
ZNTL - MDGL
51%
Loosely correlated
-12.15%
CGEM - MDGL
50%
Loosely correlated
-9.41%
More